Articles by Cynthia Challener, PhD - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

  • Search
  • Suppliers
  • Careers

Enter a company or product name

Keyword Location
About Search
Articles by Cynthia Challener, PhD

Scientific Advances in Cocrystals are Offset by Regulatory Uncertainty

Drug developers are taking a wait-and-see approach to the use of cocrystals.
May 2, 2014

Drug developers are taking a wait-and-see approach to the use of cocrystals.

Process Design Is Critical for Commercial Manufacture of HPAPIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
May 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Packaging Becomes Enabler for Biopharmaceuticals

May 2, 2014

Once an afterthought, packaging has now become an essential component of biopharmaceutical product development and marketing.

Advances in Continuous Biopharmaceutical Manufacturing

Both upstream and downstream processes can benefit from continuous manufacturing advantages.
Apr 16, 2014

Both upstream and downstream processes can benefit from continuous manufacturing advantages.

Increased Efficiency Key to Competitiveness in Downstream Bioprocessing

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.
Apr 2, 2014

Higher antibody titers and a growing demand for smaller-volume, flexible processes are creating the need for more cost-effective downstream processing.

Appropriate Process Design Critical for Commercial Manufacture of Highly Potent APIs

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.
Apr 2, 2014

Increasing potency and growing interest in antibody-drug conjugates are creating challenges for manufacturers of HPAPIs.

Drug Delivery Technologies Provide Growth Opportunities for Biopharmaceuticals

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.
Apr 1, 2014

Advanced drug delivery technologies can increase efficacy and safety, extend patent lives, and provide competitive differentiation for biopharmaceuticals.

Synthetic Biology Stirs Interest in Greener, More Efficient Processes

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Apr 1, 2014

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

Synthetic Biology: The Next Frontier in Chiral Chemistry for API Synthesis

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.
Mar 2, 2014

The commercial availability of an increasing diversity of enzymes has led to the growing use of biocatalysts for API synthesis.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
FindPharma Custom Search
Click here